Branched chain amino acid transaminase 1

BCAT1
Identifiers
AliasesBCAT1, BCATC, BCT1, ECA39, MECA39, PNAS121, PP18, branched chain amino acid transaminase 1
External IDsOMIM: 113520; MGI: 104861; GeneCards: BCAT1
Available structures
PDBOrtholog search: PDBe RCSB
Enzyme activity
EC #BRENDAExPASyKEGGMetaCyc
2.6.1.42↗↗↗↗
Orthologs
DatabasesNCBI: entry; OMA: entry
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_001178091
NM_001178092
NM_001178093
NM_001178094
NM_005504

NM_001024468
NM_007532

RefSeq (protein)

NP_001171562
NP_001171563
NP_001171564
NP_001171565
NP_005495

NP_001019639
NP_031558

Location (UCSC)Chr 12: 24.81 – 24.95 MbChr 6: 144.94 – 145.02 Mb
PubMed search
Wikidata
View/Edit HumanView/Edit Mouse

Branched chain amino acid transaminase 1 is a protein that in humans is encoded by the BCAT1 gene. It is the first enzyme in the branched-chain amino acid (BCAA) degradation pathway and facilitates the reversible transamination of BCAAs and glutamate. BCAT1 resides in the cytoplasm, while its isoform, BCAT2, is found in the mitochondria.

Function

This gene encodes the cytosolic form of the enzyme branched-chain amino acid transaminase. This enzyme catalyzes the reversible transamination of branched-chain alpha-keto acids (BCKAs) to the branched-chain amino acids (BCAAs) valine, leucine and isoleucine, which are essential for cell growth. In humans, its primary role is the deamination of BCAAs, as humans lack the enzymes for de novo synthesis of BCKAs. The respective cosubstrates are alpha-ketoglutarate and glutamate. The respective reactions are:

L-leucine + 2-oxoglutarate = 4-methyl-2-oxopentanoate + L-glutamate
L-isoleucine + 2-oxoglutarate = (S)-3-methyl-2-oxopentanoate + L-glutamate
L-valine + 2-oxoglutarate = 3-methyl-2-oxobutanoate + L-glutamate

Cells can further degrade BCKAs by the branched-chain keto acid dehydrogenase complex from which the carbon backbones of each BCAA may enter distinct degradation pathways.

The oncogenic transcription factor Myc is frequently reported to drive BCAT1 expression.

Clinical significance

Overexpression of BCAT1 has been associated with a variety of cancers, among them glioblastoma, breast cancer, acute myeloid leukemia, gastric cancer and chronic myeloid leukemia.